image505
  • Home
  • Who We Are
  • News
  • For Patients
  • Technology
  • Investors
  • Contact Us
  • Development Program
  • Stem Cell Research in AMD
  • More
    • Home
    • Who We Are
    • News
    • For Patients
    • Technology
    • Investors
    • Contact Us
    • Development Program
    • Stem Cell Research in AMD
image506
  • Home
  • Who We Are
  • News
  • For Patients
  • Technology
  • Investors
  • Contact Us
  • Development Program
  • Stem Cell Research in AMD

Highlights from the Podium and In the News

Publication in Science and Translational Medicine

Publication in Science and Translational Medicine

Publication in Science and Translational Medicine

image507

Publication of preliminary results from our Phase 1/2a clinical trial in dry age-related macular degeneration - The cover story in Science Translational Medicine  

Read more

AARP - Medical Breakthroughs of 2020

Publication in Science and Translational Medicine

Publication in Science and Translational Medicine

image508

AARP highlights RPT Study participant in:   Saving Their Health and Ours.  Medical Breakthroughs of 2020

Read more

First Step

Publication in Science and Translational Medicine

Hope is in Sight for Dry AMD: First-in-Kind Stem Cell-Based Retinal Implant

image509

A video produced by the Roski Eye Institute - highlighting the first implant procedure

Click to Watch

Hope is in Sight for Dry AMD: First-in-Kind Stem Cell-Based Retinal Implant

Hope is in Sight for Dry AMD: First-in-Kind Stem Cell-Based Retinal Implant

Hope is in Sight for Dry AMD: First-in-Kind Stem Cell-Based Retinal Implant

image510

A participant in our clinical trial shares her story.

Click to Watch

Vision for the Future: Stem Cell Therapy for Eye Disease

Hope is in Sight for Dry AMD: First-in-Kind Stem Cell-Based Retinal Implant

Vision for the Future: Stem Cell Therapy for Eye Disease

image511

RPT co-founder Dr. Dennis Clegg describes the recent strategies to develop a regenerative patch for the treatment of age-related macular degeneration by developing a cellular therapy using stem cells. 

Click to watch

TEDx talk - Stemming Vision Loss with Stem Cells

Hope is in Sight for Dry AMD: First-in-Kind Stem Cell-Based Retinal Implant

Vision for the Future: Stem Cell Therapy for Eye Disease

image512

TEDx talk - Stemming Vision Loss with Stem Cells-  RPT co-founder Dr. Dennis Clegg    


Find out more

Featured in National Geographic

Featured in National Geographic

Featured in National Geographic

image513

Why There’s New Hope About Ending Blindness  

Find out more

The Story of Sight

Featured in National Geographic

Featured in National Geographic

image514

Highlighted in the documentary Story of Sight 

Click to see a preview

From the Podium

Development of a Bio-Engineered Implant for AMD Treatment

 Dr. Jane Lebkowski shares her presentation from the virtual 2020 Cell & Gene Meeting on the Mesa, describing RPTs program and development our bio-engineered implant for the treatment of AMD  

Download PDF

publications

 

Surgical  Method for Implantation of a Biosynthetic Retinal Pigment Epithelium  Monolayer for Geographic Atrophy: Experience from a Phase 1/2a Study.

Kashani AH, Uang J, Mert M, Rahhal F, Chan C, Avery RL, Dugel P, Chen S, Lebkowski J, Clegg DO, Hinton DR, Humayun MS. Ophthalmol Retina. 2020 Mar;4(3):264-273. 


Subretinal Implantation of a Human Embryonic Stem Cell-Derived Retinal Pigment Epithelium Monolayer in a Porcine Model.

Kashani AH, Martynova A, Koss M, Brant R, Zhu DH, Lebkowski J, Hinton D, Clegg D, Humayun MS.

Adv Exp Med Biol. 2019;1185:569-574. 


A Bioengineered Retinal Pigment Epithelial Monolayer for Advanced, Dry Age-Related Macular Degeneration.

Kashani AH, Lebkowski JS, Rahhal FM, Avery RL, Salehi-Had H, Dang W, Lin CM, Mitra D, Zhu D,  Thomas BB, Hikita ST, Pennington BO, Johnson LV, Clegg DO, Hinton DR, Humayun MS. Sci Transl Med. 2018 Apr 4;10(435). pii: eaao4097. 


Copyright © 2018 Regenerative Patch Technologies, LLC - All Rights Reserved.